Who to call at XBIOTECH INC., and when
Fundz watches for the moments XBIOTECH INC. starts buying, and tells you who to reach.
- An alert the day XBIOTECH INC. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at XBIOTECH INC., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at XBIOTECH INC.. With Fundz connected, it knows.
XBIOTECH INC.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.xbiotech.comAI Executive Summary
AI-powered analysis of 8-K filing content
XBiotech filed an amended 8-K/A to restate the description of director Craig Rademaker's outside role, clarifying that he is a consultant to several Canadian private equity firms with responsibilities principally in capital markets activities. The change refines disclosure of a director's outside affiliations and carries no direct financial impact.
Key Takeaways
The filing is an 8-K/A that corrects and restates one sentence from the company's June 24, 2025 8-K about director Craig Rademaker.
Rademaker is described as a consultant to a number of Canadian private equity firms, not an employee or principal of a single firm.
3 more takeaways
Related Filings (1)
1 more filing from XBIOTECH INC. in the last 90 days
Filing Overview
What This Means
XBIOTECH INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.